verified SJR 1,123 · Q2 • database Scopus / SJR & Web of Science indexed

United States · Lippincott Williams and Wilk...

workspace_premium Q2 — Oncology lock Subscription

Current Opinion in Oncology

Current Opinion in Oncology is a journal indexed in SJR in Oncology and Cancer Research with an H index of 106. It has an SJR impact factor of 1,123 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 1,123.

ISSN: 1040-8746

Publisher: Lippincott Williams and Wilkins

Category: Oncology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,123 Q2

H-index 106

Acceptance rate pie_chart

25% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,123

H-index

106

Docs (year)

Docs 3y

285

Total refs

4370

Cites 3y

771

Citable 3y

260

Cites/Doc 2y

2.39

Ref/Doc

46.99

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Brain and nervous system

What to do with incidental thyroid nodules identified on imaging studies? Review of current evidence and recommendations

Computational analysis of flow cytometry data in hematological malignancies

Combining immunotherapy and radiotherapy in head and neck squamous cell cancers

Clofarabine and nelarabine: two new purine nucleoside analogs

Chronic myelogenous leukemia

Chronic lymphocytic leukemia: advances in biology and therapeutics

Challenges of denosumab in giant cell tumor of bone, and other giant cell-rich tumors of bone

Challenges in breast cancer clinical trial design in the postgenomic era

Central nervous system germ cell tumors

Cellular adoptive immunotherapy after allogeneic stem cell transplantation

Cancer therapy and p53

SHOW MORE ARTICLES

Cancer survivorship

Acute progranulocytic leukemia

Bibliography Current World Literature

B-cell activation and lymphoma in patients with HIV

Antibodies in the treatment of human cancer

Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitations

Allogeneic haematopoietic stem cell transplantation in myelodysplastic syndromes

Advances in the pathobiology and treatment of Kaposi sarcoma

Advances in the management of asymptomatic myeloma

Adrenocortical carcinoma

FAQs

Current Opinion in Oncology has an SJR of 1,123 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Current Opinion in Oncology is 25%.

Current Opinion in Oncology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Current Opinion in Oncology?

What is the APC / publication cost?

What is the acceptance rate?